HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C F Sier Selected Research
C F Sier Research Topics
Disease
3
Neoplasms (Cancer)
05/2001 - 06/2000
2
Carcinoma (Carcinomatosis)
05/2009 - 06/2000
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2009
1
Multiple Sclerosis
10/2001
1
Leukemia
12/2000
1
Infections
12/2000
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2000
1
Pathologic Processes
12/2000
1
Disease Progression
12/2000
1
Circulating Neoplastic Cells
12/2000
1
Urinary Bladder Neoplasms (Bladder Cancer)
06/2000
1
Neoplasm Metastasis (Metastasis)
06/2000
Drug/Important Bio-Agent (IBA)
3
Urokinase Plasminogen Activator Receptors
IBA
10/2001 - 12/2000
2
Plasminogen Activators (Plasminogen Activator)
IBA
10/2001 - 12/2000
2
Enzymes
IBA
10/2001 - 12/2000
2
Immunosorbents
IBA
10/2001 - 12/2000
2
Matrix Metalloproteinases (MMPs)
IBA
10/2001 - 06/2000
2
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
10/2001 - 12/2000
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
05/2009
1
Endoglin
IBA
05/2009
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
05/2009
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2009
1
Metalloproteases (Metalloproteinases)
IBA
10/2001
1
Matrix Metalloproteinase Inhibitors
IBA
05/2001
1
Plasminogen
IBA
12/2000
1
Gelatinases
IBA
06/2000
1
Tumor Biomarkers (Tumor Markers)
IBA
06/2000
Therapy/Procedure
1
Drug Therapy (Chemotherapy)
12/2000